首页 | 本学科首页   官方微博 | 高级检索  
     

伪膜性肠炎诊治进展
引用本文:田小兰,吴克利. 伪膜性肠炎诊治进展[J]. 国外医学:内科学分册, 2007, 34(8): 464-466
作者姓名:田小兰  吴克利
作者单位:海南省人民医院消化内科,海南海口570311
摘    要:伪膜性肠炎常发生于应用抗生素之后,发病率有呈上升趋势.主要表现为腹泻、腹痛、发热及血象升高.在使用抗生素治疗期间或者之后6~8周出现腹泻均应考虑该诊断.合理使用抗生素是预防关键.灭滴灵及万古毒素目前仍是最有效的治疗药物.难辨梭菌类毒素疫苗的接种成功为复发高危患者带来了希望.

关 键 词:伪膜性肠炎  抗生素  腹泻
文章编号:1004-2369(2007)08-0464-03
修稿时间:2007-03-29

Update on diagnosis and treatment of pseudomembranous colitis
TIAN Xiao-lan,WU Ke-li. Update on diagnosis and treatment of pseudomembranous colitis[J]. Foreign Medical Sciences(Section of Internal Medicine), 2007, 34(8): 464-466
Authors:TIAN Xiao-lan  WU Ke-li
Abstract:Pseudomembranous colitis usually develops after antibiotics administration. The morbidity is gradually ascending. Its manifestations are diarrhea, abdominal pain, fever and increase of white blood cells. The diagnosis should be suspected in any patient who develops diarrhea during antibiotic therapy or within 6-8 weeks of treatment. The key to prevent Pseudomembranous colitis is to administrate antibiotics rationally. Metronidazole and vancomycin are still the most effective drugs to treat the disease. A Clostridium difficile toxoid vaccine successfully induced immune responses to toxins A and B brings hope to those individuals who are recurrent high-risk patients.
Keywords:Pseudomembranous colitis    Antibiotics    Diarrhea
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号